Gapping down
In reaction to disappointing earnings/guidance:
- WSBC -23.2%, HLIT -10.1%, SANM -7.7%, IBTX -5.5%, JJSF -3.6%, UPS -3.5%, NOV -3.2%, UHS -2.9%, CE -2.3%, MRK -1.9%, XRX -1.8%, CNC -1.7%, BP -1.6%, CINF -1.1%, WAT -1%, PPG -0.9%, CR -0.9%, QTS -0.8%, IQV -0.8%
Other news:
- NBSE -15.7% (stock offering)
- BPMC -14.7% (announces top-line results from the Phase 3 VOYAGER clinical trial of avapritinib versus regorafenib)
- AGLE -11.7% (commences $100 mln common stock offering)
- SPPI -7.2% (provides strategy update for Phase 2 ZENITH20 clinical trial evaluating poziotinib)
- CLB -1.3% (to join S&P SmallCap 600)
Analyst comments:
- BNTX -1.8% (downgraded to Neutral from Buy at BofA/Merrill)
- ROKU -0.9% (downgraded to Neutral from Buy at Guggenheim)